Biopharmaceutical Applied Executive Compensation | 990 Data

Financial snapshot · TY 2024

$37K

Total revenue

$27K

Total expenses

—

Net assets

Financial health · TY 2024

Moderate financial health

Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.

Reserve ratio

100

111.4 months of expenses

Program efficiency

Program expenses as % of total

Revenue diversity

Mix of program fees, grants & contributions

No individual compensation data available.

This organization files with the IRS but does not report individual compensation on Form 990 Part VII.

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.